Definitive Contract 75A50122C00079

This contract was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Orasure Technologies Inc. to develop improvements to the OraQuick Ebola Rapid Antigen Test. The $15,504,106.00 cost-plus-fixed-fee contract aims to increase the test's sensitivity and shelf life, develop sustainable reagents, transition manufacturing to an automated line, and purchase two lots of approximately 10,000 improved tests. This is a sole-source award, as Orasure's OraQuick product is the only FDA-cleared rapid antigen test for Ebola that can be used on oral fluids from cadavers. The contract also references Orasure's existing indefinite delivery vehicle (IDV) contracts with the Defense Logistics Agency and GSA Federal Supply Schedule, which allow federal agencies to efficiently procure their diagnostic tests and supplies. No set-aside designation was used for this award.